Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema

Contact Dermatitis. 2015 Dec;73(6):366-7. doi: 10.1111/cod.12476.
No abstract available

Keywords: brimonidine tartrate; contact allergy.

Publication types

  • Case Reports

MeSH terms

  • Administration, Cutaneous
  • Adrenergic alpha-2 Receptor Agonists / adverse effects*
  • Brimonidine Tartrate / adverse effects*
  • Dermatitis, Allergic Contact / etiology*
  • Dermatologic Agents / adverse effects*
  • Facial Dermatoses / chemically induced*
  • Female
  • Gels
  • Humans
  • Rosacea / drug therapy*
  • Young Adult

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Dermatologic Agents
  • Gels
  • Brimonidine Tartrate